newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments for